Trademark: 79322364
Status Date
Tuesday, February 14, 2023
Registration Number
6976289
Registration Date
Tuesday, February 14, 2023
Filing Date
Thursday, August 5, 2021
Published for Opposition
Tuesday, November 29, 2022
5 Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer
Jan 28, 2024
New Representative At Ib Received
Jun 12, 2023
Final Decision Transaction Processed By Ib
May 17, 2023
Final Disposition Notice Sent To Ib
May 17, 2023
Final Disposition Processed
May 14, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 14, 2023
Notice Of Registration Confirmation Emailed
Feb 14, 2023
Registered-Principal Register
Dec 12, 2022
Notification Processed By Ib
Nov 29, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2022
Published For Opposition
Nov 23, 2022
Notification Of Possible Opposition Sent To Ib
Nov 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 9, 2022
Notification Of Notice Of Publication E-Mailed
Oct 27, 2022
Approved For Pub - Principal Register
Oct 7, 2022
Change Of Name/Address Rec'd From Ib
Oct 6, 2022
Teas/Email Correspondence Entered
Oct 6, 2022
Correspondence Received In Law Office
Oct 6, 2022
Teas Response To Office Action Received
Jul 5, 2022
Refusal Processed By Ib
Jun 11, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 11, 2022
Refusal Processed By Mpu
May 7, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 6, 2022
Non-Final Action Written
May 5, 2022
Assigned To Examiner
Oct 16, 2021
Application Filing Receipt Mailed
Oct 12, 2021
New Application Office Supplied Data Entered
Oct 8, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
